CO6831987A2 - Composición farmacéutica para uso de inflamación y dolor - Google Patents

Composición farmacéutica para uso de inflamación y dolor

Info

Publication number
CO6831987A2
CO6831987A2 CO13297886A CO13297886A CO6831987A2 CO 6831987 A2 CO6831987 A2 CO 6831987A2 CO 13297886 A CO13297886 A CO 13297886A CO 13297886 A CO13297886 A CO 13297886A CO 6831987 A2 CO6831987 A2 CO 6831987A2
Authority
CO
Colombia
Prior art keywords
inflammation
pain
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
CO13297886A
Other languages
English (en)
Inventor
Paniagua Maria Angelica Arzola
Lopez Enrique Raul Garcia-Salgado
Pelaez Juan Pablo Senosiain
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of CO6831987A2 publication Critical patent/CO6831987A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO13297886A 2011-06-22 2013-12-20 Composición farmacéutica para uso de inflamación y dolor CO6831987A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.

Publications (1)

Publication Number Publication Date
CO6831987A2 true CO6831987A2 (es) 2014-01-10

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13297886A CO6831987A2 (es) 2011-06-22 2013-12-20 Composición farmacéutica para uso de inflamación y dolor

Country Status (13)

Country Link
AR (1) AR086733A1 (es)
BR (1) BR112013033007A2 (es)
CL (1) CL2013003671A1 (es)
CO (1) CO6831987A2 (es)
CR (1) CR20130687A (es)
DO (1) DOP2013000309A (es)
ES (1) ES2441917B1 (es)
GT (1) GT201300318A (es)
MX (1) MX357376B (es)
NI (1) NI201300142A (es)
PE (1) PE20141530A1 (es)
RU (1) RU2604149C2 (es)
WO (1) WO2012176155A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025717B1 (en) * 2013-05-27 2018-11-07 Farmacéuticos Rayere, S.A. Synergistic pharmaceutical composition of two analgesics having a distinct pharmacokinetic profile

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
WO2007148950A1 (es) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
CR20130687A (es) 2014-02-21
ES2441917A2 (es) 2014-02-06
ES2441917B1 (es) 2014-11-25
RU2604149C2 (ru) 2016-12-10
DOP2013000309A (es) 2014-04-15
NI201300142A (es) 2015-02-25
BR112013033007A2 (pt) 2017-01-31
PE20141530A1 (es) 2014-11-12
GT201300318A (es) 2015-05-21
CL2013003671A1 (es) 2014-07-11
AR086733A1 (es) 2014-01-15
MX357376B (es) 2018-07-06
RU2013157013A (ru) 2015-07-27
ES2441917R1 (es) 2014-02-19
WO2012176155A1 (es) 2012-12-27
MX2011006758A (es) 2013-01-10

Similar Documents

Publication Publication Date Title
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
CO6862148A2 (es) Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
CO7030962A2 (es) Compuestos terapéuticamente activos y sus métodos de uso
CO7010834A2 (es) Compuestos terapéuticamente activos y sus métodos de uso
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112014003802A2 (pt) composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112013017752A8 (pt) uso de um antagonista do vegf e formulação farmacêutica
BR112014013760A2 (pt) composto, composição farmacêutica e uso de um composto
BR112013026410A2 (pt) compostos antimicrobianos e métodos de preparação e uso dos mesmos
BR112013033072A2 (pt) agente para indução de apoptose e composição farmacêutica
BR112014001991A2 (pt) certos inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso dos mesmos
BR112014005669A2 (pt) composto, composição farmacêutica e uso de um composto
CO6811867A2 (es) Cannabinoides para uso en el tratamiento del dolor neuropático
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BR112014003567A2 (pt) composto, uso de um composto, e, composição farmacêutica
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
CO6890098A2 (es) Compuesto pirazol y su uso farmaceutico
BR112014010739A2 (pt) agentes terapêuticos e uso dos mesmos
CO6970609A2 (es) Composición farmacéutica y métodos de uso de derivados de 4-pregenen-11ß-17-21-triol-3,20-diona
BR112013011845A2 (pt) produto para cuidado oral e métodos de uso e fabricação do mesmo